Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hennepin Life Sciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Hennepin Life Sciences

Hennepin Life Sciences

Hennepin Life Sciences: Developing unique, natural anti-infective compounds for human and animal health.

HQ
Plymouth, MN, US
Founded
2009
Overview
Compare
Fundraising
Employees

Hennepin Life Sciences is dedicated to developing patent-protected, naturally-derived anti-infective compounds aimed at preventing and treating various infections in both humans and animals. The company's core mission is to provide innovative health solutions that leverage natural ingredients to combat infectious diseases effectively.

Hennepin Life Sciences has achieved significant progress in the biotech sector, with its novel compounds gaining attention for their potential to address unmet medical needs. The company's impact is marked by its focus on sustainable and natural health innovations, contributing to advancements in both human and veterinary medicine.

Hennepin Life Sciences - Similar Companies

Animal Life Sciences logo

Animal Life Sciences

Revagenix logo

Revagenix

revagenix.com

Iogenetics logo

Iogenetics

iogenetics.com

Hapten Sciences logo

Hapten Sciences

haptensciences.com

BioPlx logo

BioPlx

Veloce BioPharma logo

Veloce BioPharma

Nuovo Biologics logo

Nuovo Biologics

nuovobiologics.com

Innovative Biologics logo

Innovative Biologics

Bioxiness Pharmaceuticals logo

Bioxiness Pharmaceuticals

Omni Biosciences logo

Omni Biosciences

Petri Bio logo

Petri Bio

petribio.com

Nano Cures logo

Nano Cures

nanocures.com

AMPLY Discovery logo

AMPLY Discovery

amplydiscovery.com

Mycologics logo

Mycologics

mycologics.net

ExoLytics logo

ExoLytics

exolytics.com

Hennepin Life Sciences - Quick Facts

Who are Hennepin Life Sciences' competitors?

Companies similar to Hennepin Life Sciences include Animal Life Sciences, Revagenix, Iogenetics and Hapten Sciences.

When was Hennepin Life Sciences founded?

Hennepin Life Sciences was founded in 2009.

Where is Hennepin Life Sciences' headquarters located?

Hennepin Life Sciences' headquarters is located in Plymouth, MN, US.

When was Hennepin Life Sciences' last funding round?

Hennepin Life Sciences' most recent funding round was for $1.9M (USD) in March 2017.

How much has Hennepin Life Sciences raised to-date?

As of Mar 7, 2017, Hennepin Life Sciences has raised a total of $1.9M (USD).

How many employees does Hennepin Life Sciences have?

Hennepin Life Sciences has 9 employees as of Feb 5, 2024.

Hennepin Life Sciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Anti-Infective Compounds
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified